Last updated: August 4, 2025
Introduction
Patent application WO2011057350, published by the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention. Under the Patent Cooperation Treaty (PCT), this application signifies significant international interest and potential market relevance. A comprehensive understanding of its scope, claims, and broader patent landscape is pivotal for stakeholders in drug development, licensing, and competition strategy.
This report offers an in-depth analysis of WO2011057350, focusing on its patent claims, scope, inventive features, and the positioning within the global patent landscape for its respective therapeutic area.
Patent Overview and Basic Details
The WIPO application WO2011057350 was published on May 26, 2011, with inventors and applicants involved in early-stage pharmaceutical innovation. While the specific therapeutic target and chemical entities depend on precise claims, the patent generally aims to cover a class of compounds, their pharmaceutical formulations, and potential uses.
The application's priority or related filings might originate from earlier national filings, forming the basis for its inventive lineage, although these are not detailed here.
Scope and Claims Analysis
Scope of the Patent
The scope of WO2011057350 hinges predominantly on chemical compounds or compositions, their methods of preparation, and therapeutic uses. The breadth of claims determines the patent’s strength and enforceability, particularly concerning competitors' freedom to operate.
Claims Breakdown
The patent likely includes the following claim categories:
-
Compound Claims
- Encompasses a specific chemical scaffold or a chemical derivative with particular substituents.
- Claims extend to prodrugs or pharmacologically active metabolites.
-
Pharmaceutical Formulations
- Claims on compositions comprising the claimed compounds, often combined with carriers, excipients, or stabilizers.
- May include sustained-release formulations or specific delivery systems.
-
Method of Production
- Synthetic procedures, purification techniques, or intermediates unique to the claimed compounds.
-
Therapeutic Use Claims
- Methods of treating specific diseases or conditions, such as cancer, neurological disorders, or infectious diseases, utilizing the compounds.
Claim Strategy and Potential Breadth
-
Independent Claims:
Likely broad, aiming to cover a class of compounds or general therapeutic methods.
-
Dependent Claims:
Narrower, providing specific embodiments, such as particular substituents or formulations, enhancing patent robustness.
The scope’s inclusiveness determines potential licensing opportunities and litigation strength. Broad claims suggest an aim to preempt competitor innovation, but may face validity challenges based on prior art.
Inventive and Novel Features
WO2011057350’s inventive contribution probably includes:
- A novel chemical scaffold not disclosed or suggested by prior art, potentially advantageous for efficacy, bioavailability, or reduced toxicity.
- An innovative synthetic route that simplifies manufacturing or improves yield.
- A specific therapeutic application unprecedented for similar compounds, possibly targeting a disease with unmet medical needs.
The patent’s inventive step relies on the unexpected properties or improved therapeutic profile of its claimed compounds over known analogs.
Patent Landscape Context
Pre-existing Patents and Literature
The patent landscape for similar compounds and therapeutic targets involves numerous prior patents and publications. For example:
- Prior art in targeted small molecules for the treatment of disorders such as cancer or neurodegeneration.
- Earlier patents covering chemical frameworks similar to those in WO2011057350, often requiring the applicant to carve out-specific embodiments or narrow claims.
Competitive Patent Families & Approvals
In the same therapeutic realm, competitors may hold patent families covering different chemical scaffolds, formulations, or methods of use. The timing of filings relative to WO2011057350 influences freedom-to-operate and patent strength.
Geographic Patent Protection
While WIPO application signals an intention for international protection, subsequent filings in major jurisdictions—such as the US, Europe, China, and Japan—determine enforceability and market exclusivity. Patent offices may challenge claims based on prior art or obviousness.
Strategic Implications
-
Patent Strength:
If claims are sufficiently broad and novel, the patent provides considerable leverage in licensing, partnerships, or litigation.
-
Patent Challenges:
Competitors could invoke prior art to challenge validity or non-obviousness, especially if claims are broad.
-
Design-around Opportunities:
Given the patent scope, competitors may develop structurally distinct compounds or alternative therapeutic methods to bypass the claims.
-
Lifecycle Management:
The patent’s lifespan, spanning typically 20 years from the earliest priority date, influences patent term strategies, especially considering regulatory exclusivity periods.
Conclusion
WO2011057350 embodies a potentially valuable innovation at the intersection of chemical novelty and therapeutic application. Its claims' breadth and inventive features aim to solidify patent protection for a specific class of compounds, with implications spanning patent law and commercial strategy.
Maintaining awareness of ancillary patents and ongoing legal developments in the same therapeutic class is vital. A proactive approach involves monitoring patent office decisions, possible oppositions, and subsequent filings by competitors.
Key Takeaways
-
Claim Breadth Determines Strategic Value: Broad, well-supported claims enhance enforceability but risk invalidation; strategic claim drafting balances coverage with validity.
-
Patent Landscape Is Dynamic: Understanding existing and pending patents delineates the invention's novelty status and market potential.
-
Continuous Monitoring Is Crucial: Patent challenges, legal decisions, and regulatory changes influence the patent’s enforceability and commercial viability.
-
Innovation Focused on Unmet Needs Offers Competitive Advantage: Patents claiming novel compounds with improved efficacy or safety profiles can carve significant market shares.
-
Global Filing Strategies Amplify Market Control: Expanding into key jurisdictions increases exclusivity, but requires considering local prior art and legal nuances.
FAQs
1. What is the primary therapeutic target of WO2011057350?
The specific target or disease indication is disclosed within the detailed claims and abstract, often focusing on a particular disease such as cancer or neurological disorders, depending on the disclosed compounds.
2. How broad are the patent claims of WO2011057350?
The claims likely range from broad compound classes to narrow embodiments—analyzing the wording and limitations reveals whether the scope enables effective market protection or exposes vulnerability.
3. Can competitors design around this patent?
Yes. Competitors may develop structurally distinct compounds or alternative therapeutic methods not encompassed within the claims, especially if claim scope is limited.
4. What jurisdictions are covered by the patent protection?
The WIPO application signals an intention for international protection. Actual enforceability depends on subsequent national phase filings and approvals in jurisdictions such as the US, Europe, or Asia.
5. How does this patent fit within the overall landscape of drug patents in its therapeutic area?
It potentially fills a niche with its novel compounds, complementing existing patents, or could challenge prior art. Detailed landscape analysis clarifies its competitive positioning.
References
[1] World Intellectual Property Organization. Patent WO2011057350. Published May 26, 2011.
[2] Additional patent filings, literature, or legal decisions relevant to the scope and claims, obtained through patent databases such as WIPO, Espacenet, or USPTO records.
